PUBLISHER: The Insight Partners | PRODUCT CODE: 1591413
PUBLISHER: The Insight Partners | PRODUCT CODE: 1591413
The pediatric mask market is anticipated to grow from US$ 734.04 million in 2023 and is projected to reach US$ 1,068.48 million by 2031; it is expected to register a CAGR of 4.8% during 2023-2031. The pediatric mask market growth is attributed to the increasing prevelance of respiratory disorders among pediatrics along with surge in training programs for healthcare providers.
Pediatric masks are specialized medical devices designed to deliver oxygen to patients living with respiratory disorders such as asthma, pneumonia, and others. These masks help in maintaining oxygen saturation among pediatric patients to avoid complication related to underlying conditions.
North America accounted for a major share of the global pediatric mask market in 2023. The North America pediatric mask market is segmented into the US, Canada, and Mexico. Increasing cases of respiratory diseases in the pediatric population and growing investments in medical devices are among a few factors that are projected to accelerate the growth of the pediatric masks market in North America during the forecast period.
In North America, the US holds a significant share of the pediatric masks market. The growth of the market in the country is primarily driven by the increasing prevalence of asthma, pneumonia, and sleep apnea. Further, the increasing requirement for novel pediatric masks to improve the quality of treatment is propelling the market in the US. For instance, as per the Centers for Disease Control and Prevention (CDC), ~4.6 children had asthma in 2021 in the US. According to the March of Dimes Organization, the US recorded 380,548 preterm births in 2022, representing 10.4% of live births. Apart from treating asthma patients, masks are also used for preterm births to assist them in proper breathing. Therefore, increasing preterm births and the growing prevalence of asthma in neonates are factors fueling the demand for pediatric masks in the US.
SunMed, ResMed, and Fisher & Paykel are among the companies headquartered in the US; these companies are taking strategic initiatives to translate their goals and visions into practice. For instance, Dynarex Corporation added a new suite of portable products to its innovative respiratory therapy line named Dynarex Resp-O2 in April 2024.
Growing Demand for Single-Use Pediatric Masks to Provide Market Opportunities in Future
There has been significant development in healthcare facilities and services globally, increasing the demand for various products, including single-use devices. Globally, single-use devices are widely used owing to the increasing patient safety concerns, reducing healthcare-associated infections, and better management of respiratory infectious diseases. Single-use masks are pre-sterilized and can be directly used, saving a lot of cleaning and sterilization time. These devices are widely used for handling patients suffering from highly infectious diseases, such as severe pneumonia and H1N1 influenza.
Furthermore, the rising number of emergency cases, such as asthma attacks, allergies, and trauma, along with the increasing burden of immunocompromised children prone to respiratory conditions, is expected to create growth opportunities in the coming years.
Pediatric Mask Market: Competitive Landscape and Key Developments
Koninklijke Philips NV, ResMed Inc, BLS Systems Limited, Besmed Health Business Corp, Flexicare (Group) Limited, Sleepnet Corporation, Circadiance, Dynarex Corp, Intersurgical LtdArmstrong Medical Ltd, Ambu AS, SunMed Group Holdings LLC ( AirLife), Dragerwerk AG & Co KGaA, and Fisher & Paykel Healthcare Corp Ltd are among the key companies operating in the pediatric mask market.
The US Food and Drug Administration, American College of Allergy Asthma and Immunology, and The Barcelona Institute for Global Health are among the primary and secondary sources referred to while preparing the pediatric mask market report.